Aetna Sees Rx Spending Growing 5%, Premiums At 13%
Executive Summary
Aetna sees pharmaceutical spending growing at about one-quarter the peak rate 18 months ago
You may also be interested in...
Reimportation Survey Demonstrates Rx Industry’s Public Relations Challenge
Pharmaceutical companies' opposition to importing drugs from Canada into the U.S. is "unreasonable," according to a survey of Americans released Oct. 9
Reimportation Survey Demonstrates Rx Industry’s Public Relations Challenge
Pharmaceutical companies' opposition to importing drugs from Canada into the U.S. is "unreasonable," according to a survey of Americans released Oct. 9
PPI Coverage Adjusts To Prilosec OTC; Wyeth Sees Growth For Protonix In ‘04
Wyeth expects Protonix (pantoprazole) to remain a readily available "tier 2" agent in most health plans during 2004 despite the changing dynamics in the proton pump inhibitor market
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: